UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

Therapeutic advances in neurological disorders, 2017-10, Vol.10 (10), p.343-359

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular biomarkers in multiple sclerosis

Journal of neuroinflammation, 2019-12, Vol.16 (1), p.272-272, Article 272

2019

Link zum Volltext

Verfügbarkeit prüfen

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System-A Review

Frontiers in neurology, 2019-02, Vol.10, p.53-53

2019

Link zum Volltext

Verfügbarkeit prüfen

A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

Journal of neurology, 2021-04, Vol.268 (4), p.1210-1221

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of TH17 cells in multiple sclerosis: Therapeutic implications

Autoimmunity reviews, 2020-10, Vol.19 (10), p.102647, Article 102647

2020

Link zum Volltext

Verfügbarkeit prüfen

Spectral Analysis of Heart Rate Variability: Time Window Matters

Frontiers in neurology, 2019-05, Vol.10, p.545-545

2019

Link zum Volltext

Verfügbarkeit prüfen

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

Scientific reports, 2020-04, Vol.10 (1), p.5941-5941, Article 5941

2020

Link zum Volltext

Verfügbarkeit prüfen

Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry – Implications for the norepinephrine system during inhibitory control

NeuroImage (Orlando, Fla.), 2017-08, Vol.157, p.575-585

2017

Link zum Volltext

Verfügbarkeit prüfen

How to reduce the delay of diagnosing secondary progression in multiple sclerosis

Multiple sclerosis, 2021-04, Vol.27 (4), p.646-647

2021

Link zum Volltext

Verfügbarkeit prüfen

Natalizumab during pregnancy and lactation

Multiple sclerosis, 2018-10, Vol.24 (12), p.1627-1634

2018

Link zum Volltext

Verfügbarkeit prüfen

Digital Twins for Multiple Sclerosis

Frontiers in immunology, 2021-05, Vol.12, p.669811-669811

2021

Link zum Volltext

Verfügbarkeit prüfen

Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors

Multiple sclerosis, 2013-11, Vol.19 (13), p.1792-1799

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

Lancet neurology, 2017-03, Vol.16 (3), p.189-199

2017

Link zum Volltext

Verfügbarkeit prüfen

Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease

Movement disorders, 2012-04, Vol.27 (5), p.617-626

2012

Link zum Volltext

Verfügbarkeit prüfen

Psychoneuroimmunology - psyche and autoimmunity

Current pharmaceutical design, 2012-10, Vol.18 (29), p.4485

Ziemssen, Tjalf

2012

Link zum Volltext

Verfügbarkeit prüfen

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)

Therapeutic advances in neurological disorders, 2022-01, Vol.15, p.175628642211353-17562864221135305

2022

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2316422-2316422

2024

Link zum Volltext

Verfügbarkeit prüfen

The need for a strategic therapeutic approach: multiple sclerosis in check

Therapeutic Advances in Chronic Disease, 2022-01, Vol.13, p.20406223211063032-20406223211063032

2022

Link zum Volltext

Verfügbarkeit prüfen

Differentiating societal costs of disability worsening in multiple sclerosis

Journal of neurology, 2020-04, Vol.267 (4), p.1035-1042

2020

Link zum Volltext

Verfügbarkeit prüfen

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

Frontiers in immunology, 2021-06, Vol.12, p.701752-701752

2021

Link zum Volltext

Verfügbarkeit prüfen

Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients

International journal of molecular sciences, 2022-11, Vol.23 (22), p.13759

2022

Link zum Volltext

Verfügbarkeit prüfen

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

Therapeutic advances in neurological disorders, 2016-07, Vol.9 (4), p.250-263

2016

Link zum Volltext

Verfügbarkeit prüfen

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Therapeutic Advances in Neurological Disorders, 2022-01, Vol.15, p.175628642211331-17562864221133163

2022

Link zum Volltext

Verfügbarkeit prüfen

Building digital patient pathways for the management and treatment of multiple sclerosis

Frontiers in immunology, 2024, Vol.15, p.1356436-1356436

2024

Link zum Volltext

Verfügbarkeit prüfen

A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity

Nature immunology, 2017-06, Vol.18 (6), p.654

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 484

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(414)
Mit Volltextzugriff
(433)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

Molecular biomarkers in multiple sclerosis

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System-A Review

A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

The role of TH17 cells in multiple sclerosis: Therapeutic implications

Spectral Analysis of Heart Rate Variability: Time Window Matters

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry – Implications for the norepinephrine system during inhibitory control

How to reduce the delay of diagnosing secondary progression in multiple sclerosis

Natalizumab during pregnancy and lactation

Digital Twins for Multiple Sclerosis

Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease

Psychoneuroimmunology - psyche and autoimmunity

Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC)

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab

The need for a strategic therapeutic approach: multiple sclerosis in check

Differentiating societal costs of disability worsening in multiple sclerosis

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Building digital patient pathways for the management and treatment of multiple sclerosis

A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity

Suchergebnisse filtern